Brinton pharma in talks with VCs to raise up to Rs 150 crore

MUMBAI: Tata Capital Healthcare Fund-backed Brinton Pharma is looking to raise Rs 120-150 crore in a follow on round and is in talks with venture capital funds to raise cash that would primarily be used to expand the company’s geographic footprint, said three people with direct knowledge of the deal.

“The company is on the road to raise further capital and has hired investment bank Citadel Securities to look for investors,” said one of the persons with direct knowledge of the company’s plans.

To be sure, replying to ET’s mailed queries, Brinton Pharma managing director Rahul Darda denied that the company is looking to raise funds. Tata Capital Healthcare Fund’s spokesperson did not comment.

Last March, Pune-based Brinton raised $4 million from Tata Capital Healthcare Fund in an undisclosed stake sale for its planned entry into newer areas such as paediatrics and gynaecology and to expand its international operations.

The company is currently present in eight countries, including Sri Lanka, Nepal and Bangladesh. It has registered offices in the US, UK and Ghana. The company intends to expand to West and East Africa and Southeast Asia. It earns around 75% of its revenues from the Indian market.

Brinton Pharma provides healthcare products and services for various therapeutic segments and is already present in dermatology and cosmeceuticals segments – one of the fastest growing therapeutic segments in the Indian pharmaceutical market at a 15% CAGR. The company expects its revenues from the dermatology segment to cross Rs 300 crore by FY 2020-21.

  • Related Posts

    • Pharma
    • March 27, 2024
    • 98 views
    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Haryana has blacklisted Maiden Pharmaceuticals Ltd, based at Sonepat, for three years, thereby debarring the firm from participating in state tenders. All rate contracts issued to the firm have also…

    • Pharma
    • March 27, 2024
    • 67 views
    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    New Delhi: The Drugs Consultative Committee (DCC), the advisory committee formed by the Central government to advise the Central and state governments on matters that require uniform implementation of drug laws…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Lee Health develops natural capsule for effective Heart care

    Lee Health develops natural capsule for effective Heart care

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down